By Matthew Brady A new medical technology innovation platform has been launched in Thailand, bringing together clinical and engineering expertise to accelerate the development of personalised medical devices.
Osscentric, described as a Medical Technology Innovation Sandbox, has been established as a collaboration between OsseoLabs – a spin-off from King Mongkut’s University of Technology Thonburi – and the Faculty of Medicine Ramathibodi Hospital at Mahidol University, with support from the Technology and Innovation in Life Sciences National Agency (TILSNA).
The platform is based within the Yothi Medical Innovation District in Bangkok, a cluster that brings together hospitals, universities, and research institutes within a single innovation ecosystem.
The platform is designed to bring together clinicians, engineers, and researchers within a clinical environment to co-develop medical technologies and devices. Its stated focus is on translational research, moving innovations from development into practical healthcare applications.
Ramathibodi Hospital, which sees more than 5,000 patients per day, serves as the clinical hub, providing both the patient volume for validation and regulatory oversight of any devices developed through the initiative.
Osscentric will utilise a range of technologies including 3D printing, advanced materials, AI-driven surgical planning, and digital surgical simulation. The platform is also developing magnesium-based biodegradable implants – materials designed to degrade naturally within the body, potentially eliminating the need for secondary surgeries to remove implants.
The initiative has a stated international commercial dimension. Osscentric has entered a partnership with Johnson & Johnson Innovation’s JLABS network, which is intended to connect Thai-developed innovations with global investors, industry partners, and commercialisation pathways.
No details were provided on initial funding, specific research projects under development, or a timeline for commercial outputs.
Author
Discover more from HealthTechAsia
Subscribe to get the latest posts sent to your email.